Bausch Health Companies Revenue and Competitors

Claim your profile

Laval, QC CAN

Location

$1.2B

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bausch Health Companies's estimated annual revenue is currently $8.4B per year.(i)
  • Bausch Health Companies's estimated revenue per employee is $3,405,885
  • Bausch Health Companies's total funding is $1.2B.
  • Bausch Health Companies's current valuation is $9.7B. (January 2022}

Employee Data

  • Bausch Health Companies has 2481 Employees.(i)
  • Bausch Health Companies grew their employee count by -3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.6M13117%N/AN/A
#2
$32.8M163N/AN/AN/A
#3
$15.9M79-9%N/AN/A
#4
$311.8M1551-1%N/AN/A
#5
$280M13934%N/AN/A
#6
$37.4M186-17%N/AN/A
#7
$45.6M227N/AN/AN/A
#8
$16.5M82-6%N/AN/A
#9
$19.5M97-2%N/AN/A
#10
$4.2M21N/AN/AN/A

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 21,000 employees are united around our mission of improving people's lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: People, Quality Health Care Outcomes, Customer Focus, Innovation and Efficiency. More information can be found at www.bauschhealth.com. ###

keywords:N/A

$1.2B

Total Funding

2481

Number of Employees

$8.4B

Revenue (est)

-3%

Employee Growth %

$9.7B

Valuation

N/A

Accelerator

Bausch Health Companies News

2022-04-19 - Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial ...

(NYSE/TSX: BHC) ("Bausch Health"), and Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today...

2022-04-17 - Bausch Health Stock Rises After It Gets Help With Its $22.9B Debt

Bausch Health , the specialty pharma company, is making progress in tackling its indebtedness. Bausch (ticker: BHC) said Wednesday that its...

2022-04-17 - FDA Bausch Health Companies Letter on DUOBRII Statements

FDA Issues Untitled Letter to Bausch Health Companies for Misleading Statements Relating to DUOBRII™. Wednesday, April 20, 2022. On March 31, 2022,...

2021-11-15 - Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs

LAVAL, QC and TRENTON, N.J., Nov. 15, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced its exclusive ONE by ONE and Biotrue® Eye Care Recycling programs have recycled a total of 41,358,603 ...

2021-11-04 - Bausch Health Announces Participation In Upcoming Investor Conferences

LAVAL, QC, Nov. 4, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in upcoming investor conferences. Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, executive vice presid ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$373.1M266516%N/A
#2
$8769.1M2759322%N/A